Pharmaceutical Technology on MSN
PRISM BioLab partners with Receptor.AI for molecule discovery
The collaboration targets disease areas where conventional small molecule drug discovery has faced challenges.
Vietnam Investment Review on MSN
PRISM BioLab and Receptor AI partner on drug discovery
TOKYO, March 13, 2026 /PRNewswire/ -- PRISM BioLab Co., Ltd. ("PRISM") and Receptor.AI Inc. today announced that they have entered into a drug discovery collaboration agreement (the "Collaboration") ...
A Hybrid Type III Effectiveness-Implementation Trial to Optimize Medication Safety With Oral Antitumor Therapy in Real-World: The AMBORA Competence and Consultation Center Androgen receptor pathway ...
G protein-coupled receptors (GPCRs) are essential for cell signal transduction and comprise the largest drug target protein family. Upon agonist stimulation, these receptors activate multiple ...
Drugs that target opioid receptors sometimes have severe side effects. Thousands of people around the world die every day from overdoses involving opioids such as fentanyl. An international team of ...
Recent advances in drug discovery research have led to the development of numerous drug candidate compounds with high ...
A review in the Canadian Journal of Physiology and Pharmacology examines emerging evidence linking glucagon-like peptide-1 ...
Explore NMDA receptor modulation and its critical role in neuronal development and cognitive functions like learning and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results